Peptide Medix product catalog

Research Peptides · Cat. 069-08

CR 1409, Cholecystokinin Antagonist

Supplied as 5 mg per unit. Purity ≥ 95%. Molecular weight 481.4. Species: Other species. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.

Specifications

Catalog number069-08
Product typeResearch Peptides
Peptide familyCholecystokinin (CCK)
SpeciesOther species
Unit size5 mg
Molecular weight481.4 Da
Purity≥ 95%
ValidationExhibits correct molecular weight
AppearanceWhite powder
ContentsEach vial contains 5 mg of NET peptide.
SolubilityInsoluble in water. Dissolve in DMSO. Then dilute with water or any desired buffer.
Intended useIn vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes

Sequence

DL-4-(3,4-dichlorobenzoyl-amino)-5-(di-pentylamino)-5-oxo-pentanoicacid

4 residues · MW 481.4

Storage & handling

Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.

Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.

Frequently asked

What is CR 1409, Cholecystokinin Antagonist?
CR 1409, Cholecystokinin Antagonist is a research peptide listed under catalog number 069-08 in the Cholecystokinin (CCK) family, other species sequence. It is supplied as 5 mg per unit for in vitro laboratory research.
What purity is listed for 069-08?
The imported catalog record lists ≥ 95% (exhibits correct molecular weight). Request and verify current lot-specific documentation before purchase.
How should CR 1409, Cholecystokinin Antagonist be stored?
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
What is the sequence of CR 1409, Cholecystokinin Antagonist?
The 4-residue sequence is DL-4-(3,4-dichlorobenzoyl-amino)-5-(di-pentylamino)-5-oxo-pentanoicacid, molecular weight 481.4.
What is the intended use of 069-08?
This catalog listing is for laboratory research use only. It is not represented as a drug, food, supplement, cosmetic or diagnostic product, and it is not offered for human or veterinary use.

This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.